Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I Study.
Ueno M, Morinaga S, Hashimoto Y, Umemoto K, Sasahira N, Saiura A, Seyama Y, Honda G, Ioka T, Takahashi H, Miyamoto A, Nakamori S, Unno M, Takadate T, Mizuno N, Shimizu Y, Ueno H, Sugiyama M, Fukutomi A, Shimizu S, Okusaka T, Furuse J.
Ueno M, et al. Among authors: takahashi h.
Pancreas. 2021 Jan 1;50(1):83-88. doi: 10.1097/MPA.0000000000001702.
Pancreas. 2021.
PMID: 33370027
Free PMC article.
Clinical Trial.